Preventing autoimmunity after alemtuzumab in multiple sclerosis: regulatory T cells resist expansion.

Lemtrada (alemtuzumab) - Sanofi

Preventing autoimmunity after alemtuzumab in multiple sclerosis: regulatory T cells resist expansion. (PubMed, Brain) - Oct 23, 2026 - No abstract available
Journal • CNS Disorders • Multiple Sclerosis

http://www.ncbi.nlm.nih.gov/pubmed/42904792

David P J Hunt

Oct 23, 2026